- Walgreens Boots Alliance Inc (NASDAQ:WBA) is planning to seek the help of automation for its drugstores to ease the pressure of the lack of manpower.
- The company, faced with a shortage of pharmacists and pharmacist technicians, is setting up a network of automated, centralized drug-filling centers.
- Walgreens’ plan would cut the pharmacist workloads by at least 25% in addition to saving more than $1 billion a year in costs, the Wall Street Journal reported.
- Through automation, pharmacists will have more time to attend to requirements, including vaccinations, patient outreach, and medical prescription.
- The COVID-19 pandemic has created more demand for pharmacies as they took on the jobs of vaccination and testing.
- Also Read: As Moderna Grapples With Supply Shortage, FDA Gives Nod To Additional Lots of COVID-19 Booster
- “Small chains up through the larger chains are all facing the labor shortage as well as increased demand for services,” the report quoted Alecia Lashier, chief automation officer at iA.
- iA is a provider of pharmacy automation software and technology in which Walgreens is a majority investor.
- Price Action: WBA shares are trading higher by 0.64% at $31.60 in premarket on the last check Monday.
ASE Technology Reports 16% YoY Revenue Decline In February To $1.327B, Net Revenues for ATM Decreases 17.9% YoY To $769M
ASE Technology Holding Co., Ltd. (NYSE:ASX, IEX:3711, ", , ASEH", , or the ", , Company", , )))), announces its unaudited consolidated net revenues for February 2023.
Consolidated net revenues